Glutamate toxicity on a PC12 cell line involves glutathione (GSH) depletion and oxidative stress

Free Radical Biology and Medicine

Volumn 23, Issue 4, 1997, Pages 637-647

  Pereira, Cláudia M F ^a   Oliveira, Catarina R ^a,b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Antioxidants; Cystine; Glutamate; GSH; Oxidative stress; PC12 cells

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; CYSTINE; DITHIOTHREITOL; GLUTAMIC ACID; GLUTATHIONE; GLUTATHIONE REDUCTASE; IDEBENONE; LACTATE DEHYDROGENASE; SELEGILINE;

ARTICLE; CELL DAMAGE; CELL PROTECTION; CELL STRAIN; CELL VIABILITY; CYTOTOXICITY; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN TRANSPORT;

ANIMALS; ANTIOXIDANTS; BENZOQUINONES; CELL DEATH; CYSTINE; DITHIOTHREITOL; GLUTAMIC ACID; GLUTATHIONE; GLUTATHIONE REDUCTASE; KINETICS; L-LACTATE DEHYDROGENASE; OXIDATIVE STRESS; PC12 CELLS; RATS; SELEGILINE; VITAMIN E;

EID: 0030757990     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(97)00020-8     Document Type: Article

References (46)

1. Monaghan D. T., Bridges R. J., Cotman C. W. The excitatory amino acid receptors: Their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu. Rev. Pharmacol. Toxicol. 29:1989;365-402.
2. Choi D. W. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1:1988;623-634.
3. Meldrum B., Garthwaite J. Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol. Sci. 11:1990;379-387.
4. Shimada N., Graf R., Rosner G., Heiss W.-D. Ischemia-induced accumulation of extracellular amino acids in cerebral cortex, white matter, and cerebrospinal fluid. J. Neurochem. 60:1993;66-71.
5. Koh J.-Y., Goldberg M. P., Hartley D. M., Coi D. W. Non-NMDA receptor-mediated neurotoxicity in cortical culture. J. Neurosci. 10:1990;693-705.
6. Murphy T. H., Schnaar R. L., Coyle J. T., Sastre A. Glutamate cytotoxicity in a neuronal cell line is blocked by membrane depolarization. Brain Res. 460:1988;155-160.
7. Murphy T. H., Miyamoto M., Sastre A., Schnaar R. L., Coyle J. T. Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron. 2:1989;1547-1558.
8. Schubert D., Kimura H., Maher P. Growth factors and vitamin E modify neuronal glutamate toxicity. Proc. Natl. Acad. Sci. USA. 89:1992;8264-8267.
9. Froissard P., Duval D. Cytotoxic effects os glutamic acid on PC cells. Neurochem. Int. 24:1994;485-493.
10. Greene L. A., Tischler A. S. Establishement of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. USA. 73:1976;2424-2428.
11. Duval D., Demangel C., Geahel I., Blondeau K., Marcadet A. Comparison of various methods for monitoring hybridoma cell proliferation. J. Immunol. Methods. 134:1990;177-185.
12. Bergmeyer H. U., Brent E. UV-assay with piruvate and NADH. Bergmeyer H. U. Methods of enzymatic analysis. 1974;574-579 Academic Press, New York.
13. Sedmak J. J., Grossero S. E. A rapid sensitive and versatile assay for protein using Coomassie blue G 250. Ann. Biochem. 79:1977;544-552.
14. Layne E. Spectrophotometric and turbidimetric methods for measuring proteins. Colowick S. P., Koplan N. O. Methods in enzymology. 3:1957;447-451 Academic Press, New York.
15. Golberg D. M., Spooner R. J. Glutathione reductase. Bergmeyer H. U. Methods of enzymatic analysis. 3:1987;258-265 Academic Press, New York.
16. Naito M., Umegaki H., Iguchi A. Protective effects of probucol against glutamate-induced cytotoxicity in neuronal cell line PC12. Neurosci. Lett. 186:1995;211-213.
17. Zhong L.-t., Kane D. J., Bredesen D. E. BCL-2 blocks glutamate toxicity in neural cell lines. Mol. Brain Res. 19:1993;353-355.
18. Leclerc C. L., Chi C. L., Awobuluyi M., Sucher N. J. Expression of N-methyl-D-aspartate receptor subunit mRNAs in the rat pheochromocytoma cell line PC12. Neurosci. Lett. 201:1995;103-106.
19. Casado M., L-Gaujardo A, Mellström B., Naranjo J. R., Lerma J. Functional N-methyl-D-aspartate receptors in clonal pheochromocytoma cells. J. Physiol. 490:1996;391-404.
20. Sucher N. J., Brose N., Deitcher D. L., Awobluluyi M., Gasic G. P., Bading H., Cepko C. L., Greenberg M. E., Jahn R., Heinemann S. F., Lipton S. A. Expression of endogenous NMDAR1 transcripts without receptor protein suggests posttranscriptional control in PC12 cells. J. Biol. Chem. 268:1993;22299-22304.
21. Lysko P. G., Cox J. A., Vigano A. M., Henneberry R. C. Excitatory amino acid neurotoxicity at the N-methyl-D-aspartate receptor in cultured neurons: Pharmacological characterization. Brain Res. 499:1989;258-266.
22. Kempski O. S., Volk C. Neuron-glial interaction during injury and edema of the CNS. Acta Neurochir. 60:((Suppl.)):1994;7-11.
23. Koh J.-Y., Choi D. W. Quantative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J. Neurosci. Methods. 20:1987;83-90.
24. Murphy T. H., Schnaar R. L., Coyle J. T. Immature cortical neurons are uniquely sensitive to glutamate toxicity by inhibition of cystine uptake. FASEB J. 4:1990;1624-1633.
25. Eagle H. The specific amino acid requirements of a human carcinoma cell (strain HeLa) in tissue culture. J. Exp. Med. 102:1955;37-48.
26. Bannai S. Transport of cystine and cysteine in mammalian cells. Biochem. Biophys. Acta. 779:1984;289-302.
27. Halliwell B. Oxidants and human disease: Some new concepts. FASEB J. 1:1987;358-364.
28. Kato S., Negishi K., Mawatari K., Kuo C.-H. A mechanism for glutamate toxicity in the C6 glioma cells involving inhibition of cystine uptake leading to glutathione depletion. Neuroscience. 48:1992;903-914.
29. Rego A. C., Oliveira C. R. Dual effect of lipid peroxidation on the membrane order of retinal cells in culture. Arch. Biochem. Biophys. 321:1995;127-136.
30. 2+]i increase during oxidative stress. Brain Res. 713:1996;269-277.
31. Reed D. J., Fariss M. W. Glutathione depletion and susceptibility. Pharmacol. Rev. 36:1984;25S-33S.
32. Moldéus P., Quanguan J. Importance of the glutathione cycle in drug metabolism. Pharmacol. Ther. 33:1987;37-40.
33. Reed D. J. Glutathione: Toxicological implications. Annu. Rev. Pharmacol. Toxicol. 30:1990;603-631.
34. Ben-Yoseph O., Boxer P. A., Ross B. D. Assessment of the role of the glutathione and pentose phosphate pathways in the protection of primary cerebrocortical cultures from oxidative stress. J. Neurochem. 66:1996;2329-2337.
35. Miyamoto M., Murphy T. H., Schnaar R. L., Coyle J. T. Antioxidants protect against glutamate-induced cytotoxicity in a neuronal cell line. J. Pharmacol. Exp. Ther. 250:1989;1132-1140.
36. Bruno V., Battaglia G., Copani A., Sortino M. A., Canonico P. L., Nicoletti F. Protective action of idebenone against excitotoxic degeneration in cultured cortical neurons. Neurosci. Lett. 178:1994;193-196.
37. Garrick N. A., Murphy D. L. Species differences in the diamination of dopamine and other substrates for monoamine oxidase in brain. Psychopharmacology (Berlin). 72:1980;27-33.
38. Youdim M. B. H., Heldam E., Pollard H. B., Fleming P., McHugh E. Contrasting monoamine oxidase activity and tyramine induced catecholamine release in PC12 cells and chromaffin cells. Neuroscience. 19:1986;1311-1318.
39. Chiueh C. C., Huang S. J., Murphy D. L. Enhanced hydroxyl radical generation by 2-methyl analog of MPTP: Supression by clorgyline and deprenyl. Synapse. 11:1992;346-348.
40. Cohen G. Deprenyl supresses the oxidant stress associated with increased dopamine turnover. Ann. Neurol. 26:1989;689-690.
41. Gerlach M., Riederer P., Youdim M. B. H. The molecular pharmacology of L-deprenyl. Eur. J. Pharmacol. 226:1996;97-108.
42. Barber A. J., Paterson I. A., Gelowitz D. L., Voll C. L. Deprenyl protects rat hippocampal pyramidal cells from ischemic insult. Soc. Neurosci. Abstr. 19:1993;1646.
43. Roy E., Bedard P. J. Deprenyl increases survival of rat foetal nigral neurones in culture. Neuroreport. 4:1993;1183-1186.
44. Tatton W. G., Seniuk N. A., Ju Y. H., Ansari K. S. Reduction of nerve cell death by deprenyl without monoamine oxidase inhibition. Lieberman A., Olanow O., Youdim M. B. H., Tipton K. Monoamine oxidase inhibitors in neurological diseases. 1994;217-248 Raven Press, New York.
45. Siesjö B. K., Zhao Q., Pahlmark K., Siesjö P., Katsura K-i., Folbergrová J. Glutamate, calcium, and free radicals as mediators of ischemic brain damage. Ann. Thorac. Surg. 59:1995;1316-1320.
46. Rehncrona S., Folbergrová J., Smith D. S., Siesjö B. K. Influence of complete and pronounced incomplete cerebral ischemia and subsequent recirculation on cortical concentrations of oxidized and reduced glutathione in the rat. J. Neurochem. 34:1980;477-486.